Y. Mo, M. Kang, F. Xue, S. Xu, and J. Shi, “Effectiveness and Safety of Anlotinib with or without S-1 in the Treatment of Patients with Advanced Hepatocellular Carcinoma in Chinese Population: A Prospective, Phase 2 Study”, Radiol Oncol, vol. 57, no. 3, pp. 405–410, Sep. 2023.